Ronald Hodge Sells 18,906 Shares of ReposiTrak (NYSE:TRAK) Stock

ReposiTrak Inc. (NYSE:TRAK) Director Ronald Hodge sold 18,906 shares of the firm’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was sold at an average price of $13.16, for a total transaction of $248,802.96. Following the completion of the transaction, the director directly owned 561,869 shares of the company’s stock, valued at approximately $7,394,196.04. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

ReposiTrak Price Performance

Shares of TRAK stock opened at $12.25 on Wednesday. The stock has a market capitalization of $224.05 million, a price-to-earnings ratio of 34.03 and a beta of 0.39. The company’s fifty day simple moving average is $14.01 and its two-hundred day simple moving average is $16.12. ReposiTrak Inc. has a 1 year low of $12.16 and a 1 year high of $23.72.

ReposiTrak (NYSE:TRAK) last announced its quarterly earnings results on Thursday, November 13th. The company reported $0.09 earnings per share for the quarter. ReposiTrak had a return on equity of 14.37% and a net margin of 30.52%.The company had revenue of $5.97 million during the quarter.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. BNP Paribas Financial Markets increased its position in shares of ReposiTrak by 63.5% in the second quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock worth $32,000 after purchasing an additional 634 shares during the last quarter. Ingalls & Snyder LLC grew its stake in ReposiTrak by 1.3% in the 2nd quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company’s stock worth $3,905,000 after buying an additional 2,554 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of ReposiTrak by 397.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock worth $71,000 after buying an additional 2,892 shares during the last quarter. Ellsworth Advisors LLC raised its position in shares of ReposiTrak by 10.6% during the 1st quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company’s stock valued at $634,000 after buying an additional 2,997 shares in the last quarter. Finally, Raymond James Financial Inc. lifted its holdings in shares of ReposiTrak by 22.5% during the 3rd quarter. Raymond James Financial Inc. now owns 17,359 shares of the company’s stock worth $257,000 after acquiring an additional 3,185 shares during the last quarter. Hedge funds and other institutional investors own 27.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of ReposiTrak from a “buy” rating to a “hold” rating in a research report on Sunday, December 21st. Weiss Ratings reiterated a “hold (c+)” rating on shares of ReposiTrak in a research note on Monday. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold”.

About ReposiTrak

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.